Boundless Bio, Inc. (BOLD)
2.63
+0.01
(+0.38%)
USD |
NASDAQ |
Oct 05, 13:40
Boundless Bio EPS Diluted (Quarterly) : -1.055 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.055 |
| March 31, 2026 | -0.6049 |
| December 31, 2025 | -0.5752 |
| September 30, 2025 | -0.62 |
| June 30, 2025 | -0.7012 |
| March 31, 2025 | -0.7066 |
| December 31, 2024 | -0.7381 |
| September 30, 2024 | -0.7418 |
| Date | Value |
|---|---|
| June 30, 2024 | -0.7708 |
| March 31, 2024 | -0.6933 |
| December 31, 2023 | -0.5461 |
| September 30, 2023 | -0.5923 |
| June 30, 2023 | -0.5575 |
| March 31, 2023 | -0.527 |
| December 31, 2022 | -0.5296 |
| September 30, 2022 | -0.5902 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.69M |
| Total Expenses (Quarterly) | 23.69M |
| Enterprise Value | -13.74M |
| Earnings Yield | -108.6% |
| Normalized Earnings Yield | -108.57 |